Abramson Cancer Center of the University of Pennsylvania
Last Modified: April 24, 2007
You may also use Quicktime to view the individual presentation:
Gudrun Goitein, M.D., Head Division of Radiation Medicine, Paul Scherrer Institut, CH 5232 Villigen PSI, Switzerland
iTunes Manual Instructions:
Feb 3, 2011 - A T-cell receptor-based gene therapy directed against NY-ESO-1 cancer/testis antigen may represent a new therapeutic approach for patients suffering from melanoma and synovial cell sarcoma, according to a study published online Jan. 31 in the Journal of Clinical Oncology.
Feb 3, 2011
Apr 18, 2012